The pharmaceutical company that has become central to the Danish economy is readying to cut some 5,000 jobs in its home ...

Novo Nordisk's Q2 2025 sales surge as Wegovy demand grows, driven by new obesity drug data. Click here to read an analysis of ...

A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

Medically reviewed by Femi Aremu, PharmD Key Takeaways While both contain semaglutide, Wegovy is approved specifically for weight management, whereas Ozempic is approved for the treatment of type 2 ...

Firm Novo Nordisk’s global patent is set to expire in parts of the world from early 2026, allowing cut-price ‘own-label’ ...

The Danish drugmaker said a clinical trial showed participants who got a pill form of Wegovy lost an average of 16.6 percent ...

Hi, this is Naomi. I’m off to Vienna for a diabetes conference, and I’ve come across a lesser-known GLP-1 side effect. More ...

More than half of adults who used once-weekly semaglutide for obesity treatment discontinued the drug after less than 1 year, according to data presented at the European Association for the Study of ...

It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...

GLP-1 meds include Ozempic and Wegovy, which studies show could help reduce alcohol cravings and drug dependency.

Novo Nordisk has said a real-world survey of its weight-loss therapy Wegovy shows it can reduce 'food noise', persistent, ...

Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a serious ...